News
Top Big Cap Negative News Movers Premarket: SVRA: -17% FDA Will Not Take Action on the Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosi
Nov 20, 2026 · ThinkSabio Blog
Top Big Cap Negative News Movers Premarket:
SVRA: -17% FDA Will Not Take Action on the Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) by the PDUFA Date
BLTE: -17% Extension of FDA Review Timeline for Tinlarebant NDA
ANT: -12% Recent IPO weakness
INTU: -10% Earnings
SKM: -8.5% Weakness off ANT
BJ: -6% Earnings
ROST: -6% Earnings
20-NOV-2026 09:09 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
